Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Locally Advanced or Metastatic Unresectable Non Small Cell Lung Cancer

NCT00082472 is registered in ClinicalTrials.gov with Zivena as lead sponsor.

NCT NCT00082472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00082472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Locally Advanced or Metastatic Unresectable Non Small Cell Lung Cancer
Lead sponsor
Zivena
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2004
Completion date
Not reported
Enrollment
30
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc